The comparison was made after the matching, in the age, gender, body mass index (BMI), preoperative C-reactive protein (CRP), carcino-embryonic antigen (CEA), tumor diameter, and tumor-node-metastasis (TNM) staging of patients. This evidence concerns the gene CEACAM5 and neoplasm.